Anacor Pharma, GSK widen R&D pact
With this revised deal, Anacor has decided to give an option to GSK for extending its rights for the bacterial enzyme targeting LeuRS, as well as to add
Amgen has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Repatha (evolocumab) supporting its broader use prior to a first heart attack or stroke.